Finance

Lists
688739:SHA
Liaoning Chengda Biotechnology Co Ltd
CN¥20.76
+1.57%
(+0.32) 1D
Oct 16, 11:29:48 AM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688739...
Open
CN¥20.59
High
CN¥20.89
Low
CN¥20.59
Mkt. cap
8.70B
Avg. vol.
1.56M
Volume
798.82K
Dividend
0.48%
Quarterly dividend
CN¥0.02
Ex-dividend date
Jun 3, 2026
P/E ratio
197.56
52-wk high
CN¥28.43
52-wk low
CN¥18.91
EPS
CN¥0.11
No. of employees
2K
Open
CN¥20.59
High
CN¥20.89
Low
CN¥20.59
Mkt. cap
8.70B
Avg. vol.
1.56M
Volume
798.82K
Dividend
0.48%
Quarterly dividend
CN¥0.02
Ex-dividend date
Jun 3, 2026
P/E ratio
197.56
52-wk high
CN¥28.43
52-wk low
CN¥18.91
EPS
CN¥0.11
No. of employees
2K
News stories
From web sources and news partners
About Liaoning Chengda Biotechnology Co Ltd
CEO-
Employees1.58K
FoundedJun 17, 2002
Headquarters-
SectorBiotechnology
Websitecdbio.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
389.11M
294.40M
273.35M
403.92M
Cost of goods sold
62.15M
182.56M
70.94M
131.75M
Cost of revenue
62.15M
182.56M
70.94M
131.75M
Research and development expenses
89.39M
82.63M
52.22M
52.44M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
153.51M
167.92M
142.11M
159.46M
Operating expense
238.92M
253.11M
204.38M
225.89M
Total operating expenses
301.07M
435.67M
275.32M
357.79M
Operating income
88.04M
-141.27M
-1.97M
46.13M
Other non operating income
793.05K
-2.48M
-1.62M
1.41M
EBT including unusual items
65.19M
-41.54M
1.23M
53.72M
EBT excluding unusual items
102.13M
-140.22M
8.63M
58.83M
Income tax expense
22.67M
-8.52M
3.14M
18.53M
Effective tax rate
34.78%
20.51%
254.83%
34.49%
Other operating expenses
-5.17M
11.59M
3.29M
10.19M
Net income
42.52M
-33.02M
-1.91M
35.19M
Net profit margin
10.93%
-11.22%
-0.70%
8.71%
Earnings per share
-
-
-
-
Interest and investment income
14.42M
4.07M
12.34M
13.39M
Interest expense
-143.49K
-953.46K
-109.82K
-101.02K
Net interest expenses
14.28M
3.11M
12.23M
13.29M
Depreciation and amortization charges
-
-
-
-
EBITDA
129.29M
-98.75M
40.55M
105.56M
Gain or loss from assets sale
-278.06K
601.00
-
34.56K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps